Publications of Julia Sacher
All genres
Journal Article (57)
2011
Journal Article
36 (6), pp. 375 - 382 (2011)
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: An [(11)C]-harmine PET study. Journal of Psychiatry & Neuroscience
Journal Article
68 (8), pp. 817 - 826 (2011)
Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Archives of General Psychiatry
Journal Article
69 (9), p. 157S - 157S (2011)
Monoamine oxidase A (MAO-A)binding in prefrontal and anterior cingulate cortex in postpartum depression. Biological Psychiatry
Journal Article
41 (5), pp. 1051 - 1060 (2011)
Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits. Psychological Medicine 2010
Journal Article
67 (5), pp. 468 - 474 (2010)
Elevated brain monoamine oxidase A binding in early postpartum period. Archives of General Psychiatry
Journal Article
2010, 780645 (2010)
Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology 2009
Journal Article
24 (3), pp. 119 - 125 (2009)
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology
Journal Article
66 (12), pp. 1304 - 1312 (2009)
Brain monoamine oxidase a binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery and recurrence. Archives of General Psychiatry 2008
Journal Article
33 (17), pp. 1633 - 1641 (2008)
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology 2007
Journal Article
17 (2), pp. 102 - 7 (2007)
Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur Neuropsychopharmacol
Journal Article
191 (2), pp. 333 - 9 (2007)
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. Psychopharmacology
Journal Article
61 (9), pp. 1081 - 9 (2007)
Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry
Journal Article
10 (2), pp. 211 - 8 (2007)
Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand. Int J Neuropsychopharmacol 2006
Journal Article
188 (3), pp. 263 - 72 (2006)
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology 2005
Journal Article
31 (3), pp. 1032 - 41 (2005)
Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther. 2004
Journal Article
9 (11), pp. 823 - 832 (2004)
Therapy of treatment resistant depression: Focus on the management of TRD with atypical antipsychotics. CNS Spectrums
Journal Article
143 (6), pp. :715 - 24 (2004)
Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol. Book Chapter (1)
2017
Book Chapter
Die Rolle von hormonellen Übergangsphasen für Geschlechtsunterschiede in der psychischen Gesundheit. In: Genderperspektiven in der Medizin (GPmed): Abstractband zur Tagungsreihe an der Universität Leipzig, pp. 64 - 65 (Ed. Stengler, K.). Pöge, Leipzig (2017)
Meeting Abstract (16)
2021
Meeting Abstract
53 (Suppl. 1), pp. S603 - S604. Elsevier, Amsterdam (2021)
One-week of escitalopram administration does not change emotional and attentional responses in healthy female individuals on oral hormonal contraceptives. In European Neuropsychopharmacology, 2017
Meeting Abstract
42, M53, pp. S145 - S146. No longer published by Elsevier, New York, NY (2017)
Sex differences in the relationship between abdominal fat distribution and structural brain network. In Neuropsychopharmacology,